药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Benzonatate
Peginesatide
The risk or severity of Thrombosis can be increased when Peginesatide is combined with Sunitinib.
Benzonatate
Sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Sunitinib.
Benzonatate
Roflumilast
Roflumilast may increase the immunosuppressive activities of Sunitinib.
Benzonatate
Belinostat
The risk or severity of adverse effects can be increased when Sunitinib is combined with Belinostat.
Benzonatate
Bleselumab
The risk or severity of adverse effects can be increased when Sunitinib is combined with Bleselumab.
Benzonatate
Rozanolixizumab
The risk or severity of adverse effects can be increased when Sunitinib is combined with Rozanolixizumab.
Benzonatate
Risankizumab
The risk or severity of adverse effects can be increased when Sunitinib is combined with Risankizumab.
Benzonatate
Monomethyl fumarate
The risk or severity of adverse effects can be increased when Sunitinib is combined with Monomethyl fumarate.
Benzonatate
Tetrandrine
The risk or severity of adverse effects can be increased when Sunitinib is combined with Tetrandrine.
Benzonatate
Begelomab
The risk or severity of adverse effects can be increased when Sunitinib is combined with Begelomab.
Benzonatate
9-(N-methyl-L-isoleucine)-cyclosporin A
The risk or severity of adverse effects can be increased when Sunitinib is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.
Benzonatate
Hypericin
The risk or severity of adverse effects can be increased when Sunitinib is combined with Hypericin.
Benzonatate
Acteoside
The risk or severity of adverse effects can be increased when Sunitinib is combined with Acteoside.
Benzonatate
Deoxyspergualin
The risk or severity of adverse effects can be increased when Sunitinib is combined with Deoxyspergualin.
Benzonatate
Trofosfamide
The risk or severity of adverse effects can be increased when Sunitinib is combined with Trofosfamide.
Benzonatate
Cepeginterferon alfa-2B
The risk or severity of adverse effects can be increased when Sunitinib is combined with Cepeginterferon alfa-2B.
Benzonatate
Gusperimus
The risk or severity of adverse effects can be increased when Sunitinib is combined with Gusperimus.
Benzonatate
Mizoribine
The risk or severity of adverse effects can be increased when Sunitinib is combined with Mizoribine.
Benzonatate
Triptolide
The risk or severity of adverse effects can be increased when Sunitinib is combined with Triptolide.
Benzonatate
Ocrelizumab
The risk or severity of adverse effects can be increased when Sunitinib is combined with Ocrelizumab.